Acquisition of Temozolomide Chemoresistance in Gliomas Leads to Remodeling of Mitochondrial Electron Transport Chain

Temozolomide (TMZ) is an oral alkylating agent used for the treatment of high-grade gliomas. Acquired chemoresistance is a severe limitation to this therapy with more than 90% of recurrent gliomas showing no response to a second cycle of chemotherapy. Efforts to better understand the underlying mech...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Oliva, Claudia R., Nozell, Susan E., Diers, Anne, McClugage, Samuel G., Sarkaria, Jann N., Markert, James M., Darley-Usmar, Victor M., Bailey, Shannon M., Gillespie, G. Yancey, Landar, Aimee, Griguer, Corinne E.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society for Biochemistry and Molecular Biology 2010
Aiheet:
Bioenergetics
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3000957/
https://ncbi.nlm.nih.gov/pubmed/20870728
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1074/jbc.M110.147504
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia